Intellipharmaceutics International Short Interest Ratio and Short Volume

Short interest is the volume of Intellipharmaceutics International shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 2,200 shares of IPCIF short. 0.00% of Intellipharmaceutics International's shares are currently sold short. View details.

Intellipharmaceutics International saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 2,200 shares, an increase of 340.0% from the previous total of 500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Intellipharmaceutics International's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Intellipharmaceutics International: Regulus Therapeutics Inc. (0.00%), Aeterna Zentaris Inc. (2.67%), CannaPharmaRX, Inc. (0.00%), Novus Therapeutics, Inc. (41.50%), Guardion Health Sciences, Inc. (0.00%), Eyegate Pharmaceuticals Inc (0.58%), GT Biopharma, Inc. (0.00%), IntelGenx Technologies Corp. (0.00%), Mateon Therapeutics, Inc. (0.00%), and Intec Pharma Ltd (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.12 billion), Aon PLC ($3.76 billion), Clorox Co ($3.07 billion), ViacomCBS Inc. ($2.89 billion), Analog Devices, Inc. ($2.49 billion), Moderna, Inc. ($2.37 billion), Datadog ($2.29 billion), Uber Technologies, Inc. ($2.22 billion), Kroger Co ($2.20 billion), and Simon Property Group Inc ($1.88 billion). View all of the most shorted stocks.

Short selling IPCIF is an investing strategy that aims to generate trading profit from Intellipharmaceutics International as its price is falling. Intellipharmaceutics International's stock is trading down $0.01 today. To short Intellipharmaceutics International stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Intellipharmaceutics International will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Intellipharmaceutics International occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IPCIF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPCIF, twice per month. The most recent reporting period available is September, 30 2020.